Burt A Adelman's Net Worth
$21.3 Million
Who is Burt A Adelman?
Burt A Adelman has an estimated net worth of $21.3 Million. This is based on reported shares across multiple companies, which include BIOGEN IDEC INC., Verve Therapeutics, Inc., CATABASIS PHARMACEUTICALS INC, DYAX CORP, and BIOGEN INC.
SEC CIK
Burt A Adelman's CIK is 0001226283
Past Insider Trading and Trends
2003 was Burt A Adelman's most active year for acquiring shares with 16 total transactions. Burt A Adelman's most active month to acquire stocks was the month of October. 2005 was Burt A Adelman's most active year for disposing of shares, totalling 86 transactions. Burt A Adelman's most active month to dispose stocks was the month of August. 2007 saw Burt A Adelman paying a total of $15,258,724.00 for 359,797 shares, this is the most they've acquired in one year. In 2007 Burt A Adelman cashed out on 630,589 shares for a total of $20,649,233.43, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
BIOGEN IDEC INC. (BIIB) Snapshot price: $241.69
EVP, Portfolio Strategy
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
$73.78 | -$994,685.00 | 12.77K |
Scheduled
|
Oct 15
| ||
Form 4
|
—
|
0
|
$56.53 | -$690,000.00 | 12.77K |
Scheduled
|
Aug 30
| ||
Form 4
|
—
|
0
|
$53.50 | -$175,000.00 | 12.77K |
Scheduled
|
Aug 27
| ||
Form 4
|
—
|
0
|
$52.96 | -$431,263.22 | 12.77K |
Scheduled
|
Aug 17
| ||
Form 4
|
—
|
0
|
$53.60 | -$1,642,500.00 | 12.77K |
Scheduled
|
Jul 25 - Jul 26
| ||
Form 4
|
—
|
0
|
$49.24 | -$102,250.00 | 12.77K |
Scheduled
|
Jul 3
| ||
Form 4
| -34.19% | -6.63K |
$44.48 | -$295,073.02 | 12.77K |
Scheduled
|
Mar 20
| ||
Form 4
| +51.95% | 6.63K |
$44.11 | -$201,626.81 | 19.4K |
Mar 14
| |||
Form 4
| -48.18% | -11.87K |
$49.22 | -$584,243.14 | 12.77K |
Scheduled
|
Feb 13
| ||
Form 4
| +102.97% | 12.5K |
—
|
—
| 24.64K |
Feb 12
| |||
Form 4
| -1.05% | -129.00 |
$48.94 | -$273,868.24 | 12.14K |
Feb 6
| |||
Form 4/A
|
—
|
0
|
$36.34 | -$690,783.49 | 12.27K |
Scheduled
|
Jun 28
| ||
Form 4/A
|
—
|
0
|
$36.34 | -$690,783.49 | 12.27K |
Scheduled
|
Jun 28
| ||
Form 4
| -100.00% | -18.35K |
$42.78 | -$784,894.19 |
0
|
Scheduled
|
Sep 19
| ||
Form 4
|
∞
| 18.35K |
$43.39 | -$570,665.28 | 18.35K |
Sep 14
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Jan 3
| |||
Form 4/A
|
—
|
0
|
$41.55 | -$282,555.00 |
0
|
Scheduled
|
Jan 3
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 6
| |||
Form 4
|
—
|
0
|
$39.33 | -$1,432,555.00 | 11.5K |
Scheduled
|
Jan 3
| ||
Form 4
|
—
|
0
|
$30.77 | -$568,465.00 |
0
|
Scheduled
|
Dec 28
| ||
Form 4
|
∞
| 7.8K |
$25.79 | -$162,064.00 | 7.8K |
Scheduled
|
Sep 28
| ||
Form 4
| +36.04% | 10.2K |
$26.60 | -$120,251.00 | 38.5K |
Scheduled
|
Sep 28
| ||
Form 4
| +55.65% | 20.2K |
$23.40 | $254,488.00 | 56.5K |
Scheduled
|
Jun 28
| ||
Form 4
| +1.67% | 300 |
$23.61 | -$428,427.00 | 18.3K |
Scheduled
|
Jun 28
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 17
| |||
Form 4
|
—
|
0
|
$39.97 | -$1,109,500.00 | 38.5K |
Scheduled
|
Jan 3
| ||
Form 4
|
—
|
0
|
$37.43 | -$699,065.13 |
0
|
Scheduled
|
Dec 27
| ||
Form 4
|
—
|
0
|
$34.44 | -$623,807.68 | 12.59K |
Scheduled
|
Sep 27
| ||
Form 4
|
—
|
0
|
$36.34 | -$671,584.69 | 25.18K |
Scheduled
|
Jun 28
| ||
Form 4
|
—
|
0
|
$35.60 | -$453,704.00 | 309.8K |
May 5
| |||
Form 4
|
—
|
0
|
$31.11 | -$560,583.60 | 12.27K |
Scheduled
|
Mar 29
| ||
Form 4
| +4,460.97% | 12K |
—
|
—
| 12.27K |
Feb 6
| |||
Form 4
|
—
|
0
|
$22.85 | -$267,978.75 | 269 |
Scheduled
|
Dec 4
| ||
Form 4
|
∞
| 8.28K |
—
|
—
| 8.28K |
Nov 12
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Verve Therapeutics, Inc. (VERV) Snapshot price: $10.98
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 26
| |||
Form 5
|
—
|
0
|
—
|
—
| 428.33K |
Nov 7 - Sep 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 9
| |||
Form 4
| +114.94% | 10K |
$12.15 | $121,526.00 | 18.7K |
May 12
| |||
Form 4
| +85.11% | 4K |
$21.38 | $85,535.20 | 8.7K |
Mar 15
| |||
Form 4
|
∞
| 4.7K |
$31.34 | $147,303.64 | 4.7K |
Dec 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
CATABASIS PHARMACEUTICALS INC (ATXS) Snapshot price: $14.641
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 5
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
DYAX CORP No price found
CMO & EVP, R&D
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -208.60K |
—
|
—
|
0
|
Jan 22
| |||
Form 4
| +217.87% | 142.98K |
$1.50 | $214,688.46 | 208.6K |
Jan 13
| |||
Form 4
| +17.98% | 10K |
$1.48 | $14,800.00 | 65.63K |
Dec 22
| |||
Form 4
| +97.78% | 27.5K |
$1.48 | $40,700.00 | 55.63K |
Dec 17
| |||
Form 4
| -25.00% | -9.38K |
$15.66 | -$146,843.44 | 28.13K |
Scheduled
|
Mar 5
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 18
| |||
Form 4
|
—
|
0
|
$7.77 | -$942,862.50 | 37.5K |
Scheduled
|
Jan 2
| ||
Form 4
|
∞
| 37.5K |
$7.35 | -$68,500.00 | 37.5K |
Feb 27 - Mar 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 10
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
BIOGEN INC No price found
EVP - Research & Development
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -2.26K |
$21.21 | -$47,878.85 |
0
|
Oct 31
| |||
Form 4
|
—
|
0
|
$24.77 | -$231,383.75 | 22.6K |
Scheduled
|
Sep 25
| ||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Scheduled
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Scheduled
| |||
| No matching records found | |||||||||